tiprankstipranks
Fortrea Holdings Inc. (FTRE)
NASDAQ:FTRE
US Market
Want to see FTRE full AI Analyst Report?

Fortrea Holdings Inc. (FTRE) Stock Forecast & Price Target

111 Followers
See the Price Targets and Ratings of:

FTRE Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
5 Buy
4 Hold
1 Sell
Based on 10 analysts giving stock ratings to
Fortrea
Holdings Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FTRE Stock 12 Month Forecast

Average Price Target

$15.58
▲(50.05% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Fortrea Holdings Inc. in the last 3 months. The average price target is $15.58 with a high forecast of $20.00 and a low forecast of $9.50. The average price target represents a 50.05% change from the last price of $10.38.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","12":"$12","21":"$21","7.5":"$7.5","16.5":"$16.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.575,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,7.5,12,16.5,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.18,12.781538461538462,13.383076923076922,13.984615384615385,14.586153846153845,15.187692307692307,15.78923076923077,16.39076923076923,16.99230769230769,17.593846153846155,18.195384615384615,18.79692307692308,19.39846153846154,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.18,12.441153846153846,12.702307692307691,12.963461538461537,13.224615384615385,13.48576923076923,13.746923076923077,14.008076923076922,14.269230769230768,14.530384615384616,14.791538461538462,15.052692307692308,15.313846153846153,{"y":15.575,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.18,11.973846153846154,11.767692307692307,11.561538461538461,11.355384615384615,11.149230769230769,10.943076923076923,10.736923076923077,10.53076923076923,10.324615384615385,10.118461538461538,9.912307692307692,9.706153846153846,{"y":9.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.08,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.13,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.21,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.46,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":10.01,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.52,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":10.46,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":12.44,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":17.25,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.86,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.56,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.51,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.18,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$20.00Average Price Target$15.58Lowest Price Target$9.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on FTRE
Mizuho Securities
Mizuho Securities
$11$13
Hold
25.24%
Upside
Reiterated
05/12/26
Fortrea price target raised to $13 from $11 at MizuhoFortrea price target raised to $13 from $11 at Mizuho
Deutsche Bank  Analyst forecast on FTRE
Deutsche Bank
Deutsche Bank
$11$14
Hold
34.87%
Upside
Reiterated
05/07/26
Fortrea price target raised to $14 from $11 at Deutsche BankFortrea price target raised to $14 from $11 at Deutsche Bank
Robert W. Baird Analyst forecast on FTRE
Robert W. Baird
Robert W. Baird
$15$20
Buy
92.68%
Upside
Reiterated
05/06/26
Fortrea price target raised to $20 from $15 at BairdFortrea price target raised to $20 from $15 at Baird
Citi
$16$20
Buy
92.68%
Upside
Assigned
05/06/26
Fortrea price target raised to $20 from $16 at CitiFortrea price target raised to $20 from $16 at Citi
Bank of America Securities Analyst forecast on FTRE
Bank of America Securities
Bank of America Securities
$8$9.5
Sell
-8.48%
Downside
Reiterated
05/06/26
Bank of America Securities Keeps Their Sell Rating on Fortrea Holdings Inc. (FTRE)
Barclays Analyst forecast on FTRE
Barclays
Barclays
$11$16
Hold
54.14%
Upside
Reiterated
05/06/26
Barclays Reaffirms Their Hold Rating on Fortrea Holdings Inc. (FTRE)
Truist Financial Analyst forecast on FTRE
Truist Financial
Truist Financial
$16$19
Buy
83.04%
Upside
Reiterated
05/06/26
Analysts Conflicted on These Healthcare Names: Fortrea Holdings Inc. (NASDAQ: FTRE), Vertex Pharmaceuticals (NASDAQ: VRTX) and Nuvation Bio (NYSE: NUVB)
TD Cowen
$15$18
Buy
73.41%
Upside
Assigned
05/05/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), Standard BioTools (NASDAQ: LAB) and Fortrea Holdings Inc. (NASDAQ: FTRE)
Evercore ISI
$14
Buy
34.87%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (NASDAQ: ORIC), Fortrea Holdings Inc. (NASDAQ: FTRE) and Edwards Lifesciences (NYSE: EW)
William Blair Analyst forecast on FTRE
William Blair
William Blair
$12.25
Hold
18.02%
Upside
Reiterated
05/05/26
William Blair Remains a Hold on Fortrea Holdings Inc. (FTRE)
Jefferies Analyst forecast on FTRE
Jefferies
Jefferies
$9.5
Hold
-8.48%
Downside
Reiterated
09/08/25
Jefferies Keeps Their Hold Rating on Fortrea Holdings Inc. (FTRE)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on FTRE
Mizuho Securities
Mizuho Securities
$11$13
Hold
25.24%
Upside
Reiterated
05/12/26
Fortrea price target raised to $13 from $11 at MizuhoFortrea price target raised to $13 from $11 at Mizuho
Deutsche Bank  Analyst forecast on FTRE
Deutsche Bank
Deutsche Bank
$11$14
Hold
34.87%
Upside
Reiterated
05/07/26
Fortrea price target raised to $14 from $11 at Deutsche BankFortrea price target raised to $14 from $11 at Deutsche Bank
Robert W. Baird Analyst forecast on FTRE
Robert W. Baird
Robert W. Baird
$15$20
Buy
92.68%
Upside
Reiterated
05/06/26
Fortrea price target raised to $20 from $15 at BairdFortrea price target raised to $20 from $15 at Baird
Citi
$16$20
Buy
92.68%
Upside
Assigned
05/06/26
Fortrea price target raised to $20 from $16 at CitiFortrea price target raised to $20 from $16 at Citi
Bank of America Securities Analyst forecast on FTRE
Bank of America Securities
Bank of America Securities
$8$9.5
Sell
-8.48%
Downside
Reiterated
05/06/26
Bank of America Securities Keeps Their Sell Rating on Fortrea Holdings Inc. (FTRE)
Barclays Analyst forecast on FTRE
Barclays
Barclays
$11$16
Hold
54.14%
Upside
Reiterated
05/06/26
Barclays Reaffirms Their Hold Rating on Fortrea Holdings Inc. (FTRE)
Truist Financial Analyst forecast on FTRE
Truist Financial
Truist Financial
$16$19
Buy
83.04%
Upside
Reiterated
05/06/26
Analysts Conflicted on These Healthcare Names: Fortrea Holdings Inc. (NASDAQ: FTRE), Vertex Pharmaceuticals (NASDAQ: VRTX) and Nuvation Bio (NYSE: NUVB)
TD Cowen
$15$18
Buy
73.41%
Upside
Assigned
05/05/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), Standard BioTools (NASDAQ: LAB) and Fortrea Holdings Inc. (NASDAQ: FTRE)
Evercore ISI
$14
Buy
34.87%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (NASDAQ: ORIC), Fortrea Holdings Inc. (NASDAQ: FTRE) and Edwards Lifesciences (NYSE: EW)
William Blair Analyst forecast on FTRE
William Blair
William Blair
$12.25
Hold
18.02%
Upside
Reiterated
05/05/26
William Blair Remains a Hold on Fortrea Holdings Inc. (FTRE)
Jefferies Analyst forecast on FTRE
Jefferies
Jefferies
$9.5
Hold
-8.48%
Downside
Reiterated
09/08/25
Jefferies Keeps Their Hold Rating on Fortrea Holdings Inc. (FTRE)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fortrea Holdings Inc.

3 Months
Success Rate
6/9 ratings generated profit
67%
Average Return
+5.11%
Copying Elizabeth Anderson CFA's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +5.11% per trade.
1 Year
Michael RyskinBank of America Securities
Success Rate
7/12 ratings generated profit
58%
Average Return
-7.27%
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of -7.27% per trade.
2 Years
Michael RyskinBank of America Securities
Success Rate
7/12 ratings generated profit
58%
Average Return
-23.25%
Copying Michael Ryskin's trades and holding each position for 2 Years would result in 58.33% of your transactions generating a profit, with an average return of -23.25% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

FTRE Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
1
3
3
2
Buy
7
10
10
5
7
Hold
11
8
6
6
7
Sell
1
0
0
0
1
Strong Sell
1
1
0
0
0
total
20
20
19
14
17
In the current month, FTRE has received 9 Buy Ratings, 7 Hold Ratings, and 1 Sell Ratings. FTRE average Analyst price target in the past 3 months is 15.58.
Each month's total comprises the sum of three months' worth of ratings.

FTRE Financial Forecast

FTRE Earnings Forecast

Next quarter’s earnings estimate for FTRE is $0.18 with a range of $0.13 to $0.23. The previous quarter’s EPS was $0.16. FTRE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year FTRE has Performed in-line its overall industry.
Next quarter’s earnings estimate for FTRE is $0.18 with a range of $0.13 to $0.23. The previous quarter’s EPS was $0.16. FTRE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year FTRE has Performed in-line its overall industry.

FTRE Sales Forecast

Next quarter’s sales forecast for FTRE is $649.55M with a range of $640.69M to $667.20M. The previous quarter’s sales results were $636.50M. FTRE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year FTRE has Performed in-line its overall industry.
Next quarter’s sales forecast for FTRE is $649.55M with a range of $640.69M to $667.20M. The previous quarter’s sales results were $636.50M. FTRE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year FTRE has Performed in-line its overall industry.

FTRE Stock Forecast FAQ

What is FTRE’s average 12-month price target, according to analysts?
Based on analyst ratings, Fortrea Holdings Inc.’s 12-month average price target is 15.58.
    What is FTRE’s upside potential, based on the analysts’ average price target?
    Fortrea Holdings Inc. has 50.05% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is FTRE a Buy, Sell or Hold?
          Fortrea Holdings Inc. has a consensus rating of Moderate Buy which is based on 5 buy ratings, 4 hold ratings and 1 sell ratings.
            What is Fortrea Holdings Inc.’s price target?
            The average price target for Fortrea Holdings Inc. is 15.58. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $20.00 ,the lowest forecast is $9.50. The average price target represents 50.05% Increase from the current price of $10.38.
              What do analysts say about Fortrea Holdings Inc.?
              Fortrea Holdings Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of FTRE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.